IL18 and chronic obstructive pulmonary disease: Previous studies suggest that the downstream products of NLRP3 inflammasomes such as IL-1β or IL-18 are associated with the pathophysiology of smoke-driven chronic obstructive pulmonary disease (COPD) although direct evidence to link NLRP3 protein with the disease is sparse.